| Evaluating Intervention Responsiveness in People With Multiple Sclerosis (NCT01632293) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2012-04-01 |
| Plasma Exchanges in Multiple Sclerosis (MS) Relapses (NCT01442233) | University Hospital, Bordeaux | 2012-03-08 |
| Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis (NCT01576354) | University of Zurich | 2012-03-01 |
| Canadian Avonex PEN Productivity Study (NCT01489748) | Biogen | 2012-03-01 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis (NCT01433250) | Novartis Pharmaceuticals | 2012-02-01 |
| Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate (NCT01569451) | University of Colorado, Denver | 2012-02-01 |
| Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis (NCT01480076) | Biogen | 2012-02-01 |
| Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA) (NCT01563900) | Northwestern University | 2012-02-01 |
| Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (NCT01497262) | Novartis Pharmaceuticals | 2012-02-01 |
| Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients (NCT01516554) | Health Sciences Centre, Winnipeg, Manitoba | 2012-02-01 |
| Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers (NCT01500408) | Biogen | 2012-01-01 |
| A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients (NCT01964547) | Jazz Pharmaceuticals | 2012-01-01 |
| Multiple Sclerosis: Chi3L1 and Treatment Efficacy (NCT04289675) | Central Hospital, Nancy, France | 2012-01-01 |
| Occupational Therapy in Patients With Multiple Sclerosis (NCT01507636) | Insel Gruppe AG, University Hospital Bern | 2012-01-01 |
| Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis (NCT01517282) | MorphoSys AG | 2012-01-01 |
| Influence of Anaesthesia Type on Multiple Sclerosis Relapse (NCT06526130) | Varazdin General Hospital | 2012-01-01 |
| An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS) (NCT01535664) | Acorda Therapeutics | 2012-01-01 |
| A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis (NCT01539395) | MSDx, Inc. | 2012-01-01 |
| Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist (NCT01836055) | Wayne State University | 2012-01-01 |
| Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases (NCT02967380) | University of Southern California | 2011-12-14 |
| Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder Dysfunction (NCT01768910) | University of Zurich | 2011-12-01 |
| Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis (NCT01377870) | Royan Institute | 2011-12-01 |
| Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire (NCT01547351) | Mallinckrodt | 2011-12-01 |
| Effects of Dalfampridine on Cognition in Multiple Sclerosis (NCT02006160) | State University of New York at Buffalo | 2011-12-01 |
| Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples (NCT01465087) | Carmel Medical Center | 2011-12-01 |
| Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS) (NCT01440062) | Charite University, Berlin, Germany | 2011-12-01 |
| Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells (NCT01587690) | Rutgers, The State University of New Jersey | 2011-11-01 |
| Neuroprotection With Phenytoin in Optic Neuritis (NCT01451593) | University College, London | 2011-11-01 |
| Applying Speed of Processing Training to Individuals With Multiple Sclerosis (NCT01838824) | Kessler Foundation | 2011-11-01 |
| A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery (NCT01592552) | Sanguine Biosciences | 2011-11-01 |
| Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake (NCT01994018) | OSF Healthcare System | 2011-11-01 |
| Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (NCT01457924) | GlaxoSmithKline | 2011-11-01 |
| The Gilenya Pregnancy Registry (NCT01285479) | Novartis Pharmaceuticals | 2011-10-15 |
| Efficacy and Safety of GTR in Comparison to Copaxone® (NCT01489254) | Synthon BV | 2011-10-01 |
| Pacing Activity Self-management for Patients With Multiple Sclerosis (NCT01512329) | Vrije Universiteit Brussel | 2011-10-01 |
| Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis (NCT01324232) | Avanir Pharmaceuticals | 2011-09-08 |
| Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide (NCT01403376) | Sanofi | 2011-09-01 |
| Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients (NCT01658384) | Clinique Neuro-Outaouais | 2011-09-01 |
| Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™. (NCT01405872) | Biogen | 2011-09-01 |
| Dalfampridine for Imbalance in Multiple Sclerosis (NCT01444300) | Oregon Health and Science University | 2011-09-01 |
| Core Stability Training in Multiple Sclerosis (NCT01414725) | University of Plymouth | 2011-08-01 |
| Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies (NCT01442194) | Novartis Pharmaceuticals | 2011-08-01 |
| Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis (NCT01780792) | Ohio State University | 2011-08-01 |
| Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis (NCT01411514) | Claudio Gobbi | 2011-08-01 |
| Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis (NCT05859802) | D'Youville College | 2011-07-13 |
| Robot-assisted Training of the Upper Limb in Persons With Multiple Sclerosis: an Randomized Controlled Trial (NCT02257606) | Hasselt University | 2011-07-01 |
| Promoting Physical Activity Behavior in Persons With Multiple Sclerosis (NCT01572207) | Case Western Reserve University | 2011-07-01 |
| Hydroxyurea in Primary Progressive Multiple Sclerosis (NCT01103583) | S. Andrea Hospital | 2011-07-01 |
| Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis (NCT01572714) | Case Western Reserve University | 2011-07-01 |
| Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II (NCT01451723) | Louisiana State University Health Sciences Center in New Orleans | 2011-07-01 |
| [18F]PBR111 and Microglial Activation in Multiple Sclerosis (NCT01428505) | GlaxoSmithKline | 2011-07-01 |
| First-in-Human Study With GNbAC1 in Healthy Volunteers (NCT01699555) | GeNeuro Innovation SAS | 2011-07-01 |
| Walking With FES or AFO in People With MS With Foot Drop (NCT01977287) | Queen Margaret University | 2011-06-01 |
| Avonex PEN Satisfaction and Patients Experience Clinical Trial (NCT01366040) | Biogen | 2011-06-01 |
| Cytokine in Cerebrospinal Fluid (CSF) From Multiple Sclerosis Patients (NCT01380041) | University Hospital, Montpellier | 2011-06-01 |
| Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life (NCT01377805) | Genetic Disease Investigators | 2011-06-01 |
| Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis (NCT01395316) | University of Chicago | 2011-06-01 |
| Alexithymia Frequency and Interhemispheric Transfer in Patients With a First Demyelinating Event (NCT03796247) | University Hospital, Lille | 2011-05-02 |
| Ampyra for Optic Neuritis in Multiple Sclerosis (NCT01337986) | Washington University School of Medicine | 2011-05-01 |
| Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms (NCT01333501) | Novartis Pharmaceuticals | 2011-05-01 |
| Mindfulness Based Stress Reduction in Multiple Sclerosis (MS) (NCT01419301) | Stony Brook University | 2011-05-01 |
| Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI) (NCT01356134) | Genetic Disease Investigators | 2011-05-01 |
| Task-oriented Circuit Class Training in Multiple Sclerosis Subjects (NCT01464749) | University Hospital of Ferrara | 2011-05-01 |
| Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis (NCT01359566) | XenoPort, Inc. | 2011-05-01 |
| Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis (NCT01207856) | University Hospital, Bordeaux | 2011-05-01 |
| A Pilot Study of Lithium in Progressive Multiple Sclerosis (NCT01259388) | VA Office of Research and Development | 2011-05-01 |
| Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients (NCT01333358) | Central Texas Neurology Consultants | 2011-05-01 |
| Longitudinal Pharmacokinetic, Pharmacodynamic, Immunological, and Biochemical (NCT01330498) | John F. Foley, MD | 2011-04-01 |
| Robot-assisted Gait Training in Multiple Sclerosis Subjects (NCT01435694) | University Hospital of Ferrara | 2011-04-01 |
| Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for Physiotherapists (NCT02346279) | Institut fuer Physiotherapieforschung | 2011-04-01 |
| Nurse-Led Manualized Telephone Support Intervention (NCT01302431) | University of Dublin, Trinity College | 2011-04-01 |
| Psychometric Validation of Cognitive Endpoints (NCT01335633) | Kessler Foundation | 2011-03-01 |
| Rehabilitation in Multiple Sclerosis: Influence of Exercise on Development of Insulin Resistance, Muscle Power and Aerobic Capacity (NCT01718392) | Hasselt University | 2011-03-01 |
| Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis (NCT01328379) | Acorda Therapeutics | 2011-03-01 |
| Mobility Enhancing Nursing Intervention (NCT02198599) | Zurich University of Applied Sciences | 2011-03-01 |
| MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia (NCT01556685) | Biogen | 2011-03-01 |
| Falls Prevention and Balance Rehabilitation in Multiple Sclerosis (NCT02390830) | Fondazione Don Carlo Gnocchi ETS | 2011-03-01 |
| Development and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple Sclerosis (NCT01303770) | Tel Aviv University | 2011-02-01 |
| An Observational Post-Marketing Safety Registry of Sativex® (NCT02073474) | Jazz Pharmaceuticals | 2011-02-01 |
| Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program (NCT01281657) | Novartis | 2011-02-01 |
| The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis (NCT01455220) | University of South Florida | 2011-01-01 |
| Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab (NCT01250678) | Cantonal Hospital of St. Gallen | 2011-01-01 |
| Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate (NCT01454791) | Brown, Theodore R., M.D., MPH | 2011-01-01 |
| The French Multiple Sclerosis Registry (NCT02889965) | Hospices Civils de Lyon | 2011-01-01 |
| The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis (NCT01280539) | Hasselt University | 2011-01-01 |
| Motor Training and White Matter in Multiple Sclerosis (MS) (NCT01279655) | Hasselt University | 2011-01-01 |
| Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis (NCT01271699) | CENTOGENE GmbH Rostock | 2011-01-01 |
| Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis (NCT01250665) | Cantonal Hospital of St. Gallen | 2011-01-01 |
| Observational Study on Multiple Sclerosis (NCT04133779) | Fondazione Italiana Sclerosi Multipla | 2010-12-29 |
| National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis (NCT02937285) | Rennes University Hospital | 2010-12-06 |
| Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases (NCT01384825) | Fondazione Italiana Sclerosi Multipla | 2010-12-01 |
| Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials. (NCT01235221) | Biogen | 2010-12-01 |
| Mesenchymal Stem Cell Transplantation in MS (NCT01228266) | Albert Saiz | 2010-12-01 |
| A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis (NCT01318421) | Elan Pharmaceuticals | 2010-12-01 |
| Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) (NCT01440101) | Biogen | 2010-11-01 |
| Lubiprostone in Patients With Multiple Sclerosis Associated Constipation (NCT01236534) | University of Rochester | 2010-11-01 |
| A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis (NCT01356940) | Brown, Theodore R., M.D., MPH | 2010-11-01 |
| Sodium Intake in Multiple Sclerosis (NCT01846234) | Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia | 2010-11-01 |
| Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples (NCT01206023) | Carmel Medical Center | 2010-11-01 |
| The Effects of Attention Retraining in MS (NCT01492023) | Finnish MS Society | 2010-11-01 |